Search results
‘Real chances to do some good’: Richmond Hill student who won Canada-Wide Science Fair prize hopes...
YorkRegion.com· 4 days agoBefore the World Bank agreed to hear his proposal for a test that could save thousands of lives,...
EU approves Sanofi drug for chronic lung disease
Medical Xpress· 4 days agoThe European Union has approved Sanofi and Regeneron's blockbuster drug Dupixent for the treatment of chronic obstructive pulmonary disease (COPD), the...
French Stocks Lead Europe as Sunday Vote Nears; Tech Outperforms
Bloomberg via Yahoo Canada News· 4 days ago(Bloomberg) -- French stocks outperformed the broader European benchmark on Wednesday, as the...
Bain, Cinven Weighing Joint Bid for $20 Billion Sanofi Unit
Bloomberg· 4 days agoPrivate equity firms Bain Capital and Cinven are exploring a potential joint bid for French...
GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
Barrons.com· 4 days agoCureVac is also eligible for future royalties. CureVac shares jumped 12% in early trading Wednesday,...
Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Zacks via Yahoo Finance Canada· 5 days agoRegeneron (REGN) and partner Sanofi get approval for their blockbuster drug Dupixent for the chronic...
Tesla Deliveries Surprised. 3 Ways Elon Musk Can Drive the Stock Forward and a Few Other Things to...
Barrons.com· 5 days agoPowell says the Fed still needs more confidence to cut rates, Moderna is tapped to develop a bird...
Biotech Firm Targets Big Pharma With Drug-Tweak Patent Strategy
Bloomberg Law· 5 days agoA neuroscientist-led startup is borrowing a page from Big Pharma’s playbook, taking advantage of drug-approval shortcuts while securing advancements in psychiatric treatments—including in the ...
Boiron And Two More High-Yielding Dividend Stocks From Euronext Paris
Simply Wall St. via Yahoo Finance Canada· 5 days agoAmid a backdrop of heightened political uncertainty and rising bond yields in France, investors are...
EU approves Sanofi's Dupixent for 'smoker's lungs'
AOL· 5 days agoThe EU Commission approved Dupixent to treat chronic obstructive pulmonary disease (COPD) in patients that cannot be helped by standard inhaled drugs, Sanofi said in a statement ...